The best of oncology session at the RCR Annual Conference
The ORF functions to provide clinical oncology trainees within the College representation and consists of an elected trainee from every region.
Are you interested in hearing a snapshot of practice-changing updates in oncology over the past year?
We were delighted when the Oncology Registrars’ Forum (ORF) was tasked with putting together a session for the RCR Annual Conference, and co-chair Dr Mariam Obeid and I are excited to discuss the ‘The best of oncology’.
Thanks to contributions from our expert speaker faculty, this session is suitable for every attendee – consultants, registrars and all multidisciplinary attendees.
It will include several tumour site-specific developments in radiotherapy and systemic anti-cancer therapy and allow discussion on how these advances are improving patient outcomes and offering exciting new opportunities for managing challenging cases.
We will be starting with Dr Angela Pathmanathan, a clinical oncologist working in urological malignancies at The Royal Marsden Hospital who will be providing an overview of ultra-hypofractionation in prostate cancer.
Dr Siobhan Morrison from The Christie Hospital NHS Trust will be updating us on recent advances in the treatment of gynaecological malignancies, followed by Dr Jennifer King, also from The Christie Hospital, who will discuss what is new in the management of lung cancers. Professor Maria Hawkins (Clinical Director of CRUK City of London RADNET Radiation Research Unit, and Director of Translational Research at UCL/UCLH) will be closing the first part of the session with a discussion on the role of radiotherapy in the management of cholangiocarcinoma – I’m sure we also get an insight into some exciting new upcoming research too.
Following a live Q&A session, we will then have the opportunity to hear from some of the contributors to this year’s abstract submissions. There were some excellent abstracts reviewed and selected for inclusion in our session as follows:
- BIOPROP20: Biologically Optimised IMRT for Prostate RadiOtheraPy in 20 fractions. Hypofractionated Radiotherapy with Intra-Prostatic Boosts to Tumour Nodules in Men with Intermediate- and High-risk Prostate Cancer: A Phase II trial- 5-year outcomes.
- A systematic review of circulating predictive and prognostic biomarkers in patients with oesophageal adenocarcinoma or oesophageal squamous cell carcinoma managed with radiation.
- Predicting Anal Cancer Recurrence after Radical Chemoradiotherapy: A 10-Year Study Based on Tumour Growth Kinetics.
So please do come and join us on the first day of the conference, 12 October in Hall 11B at 12pm, for a very interesting collection of presentations.
Dr Alexander Pawsey
Speciality Registrar in Clinical Oncology, University College London Hospital, London.
Co-Chair of the Oncology Registrars’ Forum
The RCR Annual Conference takes place on 12-13 October at the ICC, Birmingham and online. There is still time to register your place online and join our programme covering sessions on clinical updates, professional development and career support – whatever your career stage.